Skip to content

Clinical trials

Phase 1/2 Immunoblastic Lymphadenopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Phase: Phase 1/2 Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20051
20062
20072
20083
20092
20101
20112
20131
20142
20151
20161
20171
20181
20191
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated4
Active, not recruiting3
Unknown status3
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
City of Hope Medical Center2
Fred Hutchinson Cancer Center2
Mayo Clinic2
National Cancer Institute (NCI)2
Northwestern University2
Acrotech Biopharma Inc.1
Asan Medical Center1
Autolus Limited1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy30
Lymphoma, Large-Cell, Anaplastic26
Lymphoma, Large B-Cell, Diffuse17
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma17
Mycosis Fungoides16
Lymphoma, Extranodal NK-T-Cell15
Lymphoma, Follicular15
Hodgkin Disease14
Lymphoma, B-Cell, Marginal Zone14
Lymphoma, Mantle-Cell14

Trials

Showing 76 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.